Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22394366.
- Also identified by DOI 10.1089/jpm.2011.0182.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prostacyclin analogues such as epoprostenol (Flolan®) are commonly used in the treatment of pulmonary arterial hypertension (PAH). However, their complex administration and significant cost may limit the access that patients with PAH have to palliative and hospice care. We herein report our experience using epoprostenol in a dedicated palliative care unit and present our inpatient protocol for the drug's administration.
Medical subject headings
- Epoprostenol
- Hypertension, Pulmonary
- Palliative Care